Review
Published on 07 Jan 2026
Comparison of the efficacy of antidiabetic agents in type 2 diabetes with MASLD: a network meta-analysis
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1659740
- 1,301 views
31 articles related to "Antidiabetic Agents"
Articles
Review
Published on 06 Jan 2025
Antidiabetic agent use and clinical outcomes in patients with diabetes hospitalized for COVID-19: a systematic review and meta-analysis
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1482853
- 4,018 views
- 4 citations
Systematic Review
Published on 27 May 2022
The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2022.895458
- 8,127 views
- 39 citations
Mini Review
Published on 23 Jan 2024
Experimental pharmacological approaches to reverse impaired awareness of hypoglycemia—a review
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1349004
- 3,097 views
- 3 citations
Review
Published on 22 Aug 2018
Spice-Derived Bioactive Ingredients: Potential Agents or Food Adjuvant in the Management of Diabetes Mellitus
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2018.00893
- 8,983 views
- 30 citations
Perspective
Published on 22 Feb 2024
Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1368481
- 9,730 views
- 34 citations
Systematic Review
Published on 16 Sep 2021
Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2021.708494
- 10,051 views
- 56 citations
Original Research
Published on 09 Sep 2025
Comparative efficacy and safety of antidiabetic agents for post-transplant diabetes mellitus: a network meta-analysis
in Nephrology
Frontiers in Medicine
doi 10.3389/fmed.2025.1653147
- 2,375 views
Mini Review
Published on 20 Nov 2023
GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1163288
- 10,331 views
- 26 citations
Systematic Review
Published on 06 Jan 2026
Novel antidiabetic agents and the risk of respiratory diseases: a systematic review and meta-analysis of 27 randomized controlled trials
in Pulmonary Medicine
Frontiers in Medicine
doi 10.3389/fmed.2025.1721311
- 1,289 views
- 1 citation
Review
Published on 22 May 2025
From malaria fighter to diabetes guardian: the emerging role of artesunate in treating diabetes and diabetic complications
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1583575
- 3,195 views
- 2 citations
Review
Published on 28 Feb 2022
Emerging Roles of Sodium Glucose Cotransporter 2 (SGLT-2) Inhibitors in Diabetic Cardiovascular Diseases: Focusing on Immunity, Inflammation and Metabolism
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.836849
- 7,264 views
- 30 citations
Review
Published on 18 Oct 2024
A critical review on diabetes mellitus type 1 and type 2 management approaches: from lifestyle modification to current and novel targets and therapeutic agents
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2024.1440456
- 35,060 views
- 26 citations
Review
Accepted on 23 Feb 2026
New pharmacological agents and emerging therapeutic targets for painful diabetic neuropathy
in Clinical Diabetes
Frontiers in Endocrinology
Case Report
Published on 02 Sep 2020
Exogenous Insulin Injection-Induced Stiff-Person Syndrome in a Patient With Latent Autoimmune Diabetes: A Case Report and Literature Review
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2020.00594
- 9,267 views
- 6 citations
Systematic Review
Published on 19 Sep 2024
Glucose metabolism impairment as a hallmark of progressive myoclonus epilepsies: a focus on neuronal ceroid lipofuscinoses
in Cellular Neuropathology
Frontiers in Cellular Neuroscience
doi 10.3389/fncel.2024.1445003
- 4,452 views
- 3 citations